About
Contact & Profiles
Research Areas
- Viral gastroenteritis research and epidemiology
- Cytomegalovirus and herpesvirus research
- Nosocomial Infections in ICU
- Escherichia coli research studies
- Respiratory viral infections research
- Antimicrobial Resistance in Staphylococcus
- Streptococcal Infections and Treatments
- Tracheal and airway disorders
Inserm
2024
Centre d’Investigation Clinique 1436
2024
Université Paris Cité
2023
Assistance Publique – Hôpitaux de Paris
2023
Hôpital Robert-Debré
2022
Respiratory syncytial virus (RSV) is the leading cause of bronchiolitis, resulting in 3 million hospitalizations each year worldwide. Nirsevimab a monoclonal antibody against RSV that has an extended half-life. Its postlicensure real-world effectiveness RSV-associated bronchiolitis unclear.
10.1056/nejmoa2314885
article
EN
New England Journal of Medicine
2024-07-10
10.1016/j.arcped.2023.01.002
article
EN
publisher-specific-oa
Archives de Pédiatrie
2023-02-21
10.1016/j.mmifmc.2022.03.187
article
FR
Médecine et Maladies Infectieuses Formation
2022-06-01
Coming Soon ...